RebeccaKummerLehmanMD

Child Neurology • Columbia, SC

Associate Professor of Clinical Pediatrics (Pediatric Neurology), University of South Carolina

Join to view full profile

Dr. Lehman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lehman's full profile

Already have an account?

Office
9 Medical Park Drive
Suite 110
Columbia, SC 29203
Phone+1 803-434-7961

Fax+1 803-758-0134

Summary

Dr. Lehman offers in-person and telehealth visits for a wide variety of neurologic disorders. She is fellowship trained in pediatric movement disorders and has a special interest in treating children and adolescents with Tic Disorders and their co-morbid conditions. She sees patients in the Columbia office on Mondays and Tuesdays and in the Orangeburg outreach office the second Tuesday of each month.

Education & Training

University of RochesterFellowship, Neuromuscular Medicine (Neurology), 2009 - 2010
University of RochesterResidency, Child Neurology, 2005 - 2010
University of RochesterFellowship, Child Neurology, 2006 - 2009
University of RochesterResidency, Pediatrics, 2004 - 2006
University of Rochester School of Medicine and DentistryClass of 2004, MD

Certifications & Licensure

SC State Medical License 2010 - 2025
NY State Medical License 2008 - 2010
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Clinical Trials

Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Start of enrollment: 2017 Oct 05
Completed
Phase 2
Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Start of enrollment: 2018 Feb 08
Completed
Phase 2
Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents Start of enrollment: 2018 May 25
Terminated
Phase 3
A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) Start of enrollment: 2018 May 31
Completed
Phase 3
A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents Start of enrollment: 2019 Aug 06
Completed
Phase 3
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents Start of enrollment: 2019 Jun 28
Completed
Phase 2
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04
Completed
Phase 2
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults Start of enrollment: 2023 Jan 31
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

32 citations
The Phenomenology of Tics and Tic-Like Behavior in TikTok.
Alonso Zea Vera, Adrienne Bruce, Jordan Garris, Laura Tochen, Poonam Bhatia
Pediatric Neurology. 2022-05-01
22 citations
Redefining the Pediatric Phenotype of X-Linked Monocarboxylate Transporter 8 (MCT8) Deficiency: Implications for Diagnosis and Therapies
Maria Matheus, Rebecca K. Lehman, Leonardo Bonilha, Kenton R. Holden
Journal of Child Neurology. 2015-04-21
4 citations
Family history in juvenile Huntington disease Do the signs point to “yes” or “very doubtful”?
Rebecca K. Lehman, Martha Nance
Neurology. 2013-03-12

Committees

Member, Tourette Association of America Medical Advisory Board 2013 - Present
Member, Child Neurology Society Scientific Committee 2014 - 2017
Member, American Academy of Neurology Education Committee 2013 - 2016

Professional Memberships

Child Neurology Society
Member
Tourette Association of America
Member
American Academy of Neurology - AAN
Fellow